From South China Morning Post
Drug maker Rohto plans clinical trials in Hong Kong as OASES’ first Japan partner
Top university research, cross-border data exchanges and access to mainland China’s large market have attracted Japanese firm Rohto Pharmaceutical to conduct clinical trials in Hong Kong, making it th...